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IT has been demonstrated that lysolecithin
(lysophosphatidyl choline, LPC) produces experimental
cholecystitis in cats mediated by arachidonic acid
metabolites. LPC is a cytolytic agent that has been postu-
lated as a contributing factor in the development of
cholecystitis in humans. The purpose of this research
was to evaluate the effect of LPC on human gall-bladder
mucosal cell phospholipase A and cyclooxygenase
activity. Gall-bladder mucosal cells were isolated from
the gall-bladders of patients undergoing routine
cholecystectomy. Fresh, isolated cells were maintained in
tissue culture and stimulated with varying doses of LIK;.
Platelet-activating factor concentration was quantitated
as an index of phospholipase A activity and prostanoids
were measured as an index of cyclooxygenase activity.
Also, the effect ofLPC on cyclooxygenase 1 and 2 expres-
sion in microsomal protein was evaluated. LPC caused
dose related increases in 6-keto-PGFla and PAF produced
by human gall-bladder mucosal cells. Exposure ofhuman
gall-bladder mucosal cells to LI failed to elicit expres-
sion of constitutive cyclooxygenase-1, while the expres-
sion of inducible cyclooxygenase-2 was increased. The
results of this study indicate that LPC induces the forma-
tion of prostanoids and PAF by human gall-bladder
mucosal cells, suggesting that this substance may pro-
mote the development of gall-bladder inflammation.
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Introduction
Lysolecithin (lysophosphatidyl choline, LPC) is
present in human bile in patients with cholecystitis
and has long been implicated in the pathogenesis of
cholecystitis.
1-6 In animals LPC instilled into the lu-
men of the gall-bladder produces gall-bladder in-
flammation with the process mediated by
eicosanoids. Platelet-activating factor (1-alkyl-2-
acetyl-SN-glycero-3-phosphocholine, PAF) is a pur-
ported mediator of inflammation and has been
found to produce experimental cholecystitis in ani-
mals.
The purpose of this study was to evaluate the
effect of LPC on human gall-bladder mucosal cell
prostanoid and PAF formation. Prostanoids and PAF
are both products of the phospholipase a metabolic
pathway.
1 It was anticipated that demonstrating al-
terations in PAF formation would suggest that LPC
produces its effect by stimulating phospholipase A
activity, as well as by altering cyclooxygenase activ-
ity.
Materials and Methods
With the approval of the St Louis University Insti-
tutional Review Board as well as informed consent,
17 patients undergoing routine cholecystectomy
took part in this study. The mean (+ S.E.M.) age of
the seven males and ten females was 47 (+ 3) years.
All specimens were opened in the operating room
and the mucosal surface evaluated by a pathologist
to ensure that the gall-bladder had no areas that were
indicative of neoplasms. Stones were present in
seven of the gall-bladders, while ten did not have
stones and were removed incidentally at the time of
liver or pancreatic resections. Six of the gall-bladders
with stones were removed by laparoscopy. The gall-
bladders used were selected to obtain specimens
with minimal inflammation and thus provide greater
mucosal cell yields.
Gall-bladder mucosal cell isolation and culture
were performed as described previously.
11 Gall-blad-
der specimens were maintained in 0.15 M NaCl solu-
tion on ice and underwent isolation of mucosal cells
within 30 min of operative removal. Blood and bile
were washed from the specimen with cold Hanks’
balanced salt solution (HBSS). The gall-bladder was
incubated with HBSS without calcium and magnes-
ium (Sigma, St Louis, MO, USA) in a 0.25% trypsin
(Sigma), 0.25% EDTA (Sigma) solution for 45 min at
37C, while shaking in a water bath (Precision Scien-
tific, Princeton, NJ, USA; speed 5). The mucosal
surface was gently scraped with a scalpel blade. The
cells were dispersed with pipette suction and disper-
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sion. The suspension was centrifuged twice at
100 x g for 5 min at 4C. The cell pellet was mixed
with 50 ml minimum essential medium (Sigma, St
Louis) with 10% foetal bovine serum (SMEM) and
centrifuged at 1000 xg for 10 min. A 50 ml Percoll
solution was prepared with SMEM according to the
density formula and the cell pellet was suspended in
the solution and centrifuged at 1400 xg for 10 min
to remove red blood cells. Subsequently, 25 ml of the
supernatant was removed and mixed with 25 ml of
SMEM and centrifuged at 2000 g for 10 min. The
pellet was washed again with 25 ml medium and
centrifuged. The cells were suspended in 10 ml of
medium and counted. Using Trypan Blue exclusion,
viability was invariably greater than 90%. The cells
were inoculated onto 35 mm type collagen coated
culture dishes (Co-star, Cambridge, MA, USA) at a
seeding density of 1 x 106 cells/well.
Cells were cultured in 5% CO2 95% air environment
at 37C in minimum essential medium containing
10% heat inactivated serum with 292 mg/1 t-gluta-
mine, 100 mg/1 streptomycin sulphate. 100 000 IU/1
penicillin G and 2.5 mg/1 amphotericin B (all from
Sigma). As evaluated by phase contrast microscopy,
the attached cell population was uniform without
evidence of blood cells. Immunoperoxidase tech-
niques
11,12 were used to characterize gall-bladder
epithelial cell specific antigens with avidin-biotin-
complex conjugated antisera (Vecta Stain ABC kit,
Vector Laboratories, Burlingame, CA, USA). Vimentin
monoclonal antibody was used as the negative con-
trol. Employing cytokeratin 19 (monoclonal anti-
cytokeratin 19, Amersham Corp., Arlington Heights,
IL, USA), immunohistochemical staining approxi-
mately 90% of the cell population stained positively.
Gall-bladder mucosal cells were evaluated after
24 h in culture to abrogate differences in the inflam-
matory characteristics of the gall-bladder present at
the time of cholecystectomy. In addition, each gall-
bladder served as its own control. Depending on the
mucosal cell yield, 12, 24 or 36 wells were utilized/
gall-bladder. Attached cells were washed twice with
10 ml Krebs-Ringer buffer (KRB, Sigma, St Louis),
and incubated for 1 h in 1 ml KRB solution in 95%
O2 5% air atmosphere. When appropriate LPC
(Sigma) was added to the incubation medium in
concentrations of 0.1, 0.25, 0.5, 1.0 and 1.5 mM and
the cells incubated for 1 h at 37C. These LPC
concentrations are within the range of LPC concen-
trations present in human bile and in experimental
animal models of gallstone formation. 2,3,<13
Following completion of the incubation period the
cells and incubation buffer were separated and the
buffer centrifuged to remove any cells and then
subsequently frozen at -70C prior to assay. The
attached cells were washed with fresh KRB and 1 ml
collagenase solution (Sigma) was added to each well
and incubated for 20 min. The cells were scraped
from the wells, centrifuged at 200 xg for 10 min and
the pellet was stored frozen at -70C. Cell protein
was determined by the method of Bradford14 on
mucosal cell specimens which were solubilized with
0.1 N NaOH for 1 h at 37C and sonicated for 10 s.
Bovine albumin was used as the standard.
The buffer was thawed and aliquots were used for
PGE, 6-keto-PGFl and PAF radioimmunoassays per-
formed in buffer samples without extraction, using
commercially available RIA kits obtained from New
England Nuclear, Dupont, Boston, MA. 1,15 Without
extraction, the RIA employed measured PGE, 6-keto-
PGFlu and PAF added to buffer solution in a linear
manner with increasing concentrations between 50
pg and 5 ng. The PGE antibody does not discriminate
well between PGE and PGE2. The 6-keto-PGFl=
antibody exhibited 2.6% cross-reactivity with PGF2u.
The PAF assay employed cross-reacts equally with
C6 and C18 PAF and acyl-PAF, but not with lyso-
PAF.la5
Lactate dehydrogenase (LDH) concentrations in
buffer samples were determined in order to estimate
the effects of LPC on gall-bladder mucosal cell integ-
rity. Using cell free supernatants, LDH activity was
measured by spectrophotometry using NADH and
sodium pyruvate as substrates. 16
Using three separate gall-bladder specimens, at-
tempts were made to determine if LPC stimulated
cyclooxygenase-1 or-2 (COX-1 or COX-2) enzyme
expression. Following 24 h of incubation attached
cells were washed twice with 10 ml KRB buffer and
incubated for I h in 1 ml KRB solution in 95% O2, 5%
air atmosphere at 37C with and without LPC (0.5
mM). After 1 h, the buffer was discarded and the cells
were washed with PBS, detached and collected. After
centrifugation at 2500 g the pellets were
resuspended in 5 ml 0.1 M Tris-HC1 pH 8.0 containing
10 mM diethylthiocarbamic acid, 5 mM EDTA, 250
lttM leupeptin, 0.1 l.tg/ml chymostatin, 2 l.tg/ml
aprotinin, 1 l.tg/ml pepstatin A, 7.2 l.tg/ml E-64, 2.5
btg/ml antipapain, and 0.1 ng/ml benzamidine (all
from Sigma). Cells were sonicated three times for
20 s each and then centrifuged again for 20 min at
10 000 xg at 4C. The supernatant was then centri-
fuged again for 2h at 100000xg at 4C. The
microsomal pellet was resuspended in 0.5 ml of
0.1 M phosphate buffer pH 8.0 and the protein con-
centration was determined.
For Western blotting 15 lttg of gall-bladder
microsomal protein per specimen was separated by
SDS-polyacrylamide gel electrophoresis.
17 All the
samples were boiled for 5 min in SDS-PAGE sample
buffer containing 2% SDS, 20% v/v
[-mercaptoethanol and 0.1% bromophenol blue,
before loading onto the gel wells. The
electrophoresis was carried out using the Bio-Rad
electrophoresis apparatus (Bio-Rad, Rockeville
Center, NY, USA). The gel was run at 100 V for 2 h.
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The polypeptides were then transferred using
electrophoresis onto nitrocellulose membranes, us-
ing the Bio-Rad transblot apparatus.
18 Transfer was
performed at 30 V for 16 h in 25 ml Tris-HC1 pH 8.3,
192 mM glycine and 20% methanol.
The nitrocellulose membranes were treated em-
ploying the Promega Biotec technique (Promega
Biotec, Madison, WI). The membranes were trans-
ferred into a solution containing 10 ml of TBS-T
(containing 100 mM Tris-HCl, pH 8.0, 150 mM NaCl
and 0.5% Tween-20) and rinsed briefly to remove any
remnants of acrylamide. The rinsed membranes were
blocked by incubating with 10 ml of TBS-T contain-
ing 1% BSA at room temperature for 30 min with
gentle shaking. The membranes were then incubated
separately with polyclonal anti-COX-l-goat antibody
(Cayman, Ann Arbor, MI, diluted 1:100) and
polyclonal anti-COX-2-rabbit antibody (Oxford Bio-
medical, Oxford, MI, diluted 1:100) at room tempera-
ture for 3 h with gentle shaking. As positive controls,
100 ng of COX-1 (Cayman) or COX-2 protein (Ox-
ford) was added to the membranes. The nitrocellu-
lose membranes were then washed with TBS-T three
times for 10 min each to remove unbound antibod-
ies.
Subsequently, the membranes were transferred
into solutions containing 7.5 ml of secondary anti-
bodies and incubated at room temperature for 1 h.
For COX-1 detection rabbit anti-goat IgG alkaline
phosphatase conjugate (Bio-Rad, 1:3000 dilution)
was employed and for COX-2 goat anti-rabbit IgG
alkaline phosphatase conjugate (Bio-Rad, 1:3000 di-
lution) was used as the secondary antibody. The
membranes were then washed with 200 ml of TBS-
T three times as before. The membranes were blotted
on damp filter paper and transferred to 5 ml of colour
development substrate solution consisting of 33 }.tl of
NBT substrate containing 50 mg/ml in a 70% solution
of N,N-dimethylformamide (Sigma) added to 5 ml of
alkaline phosphatase buffer containing 100 mM Tris-
HCl pH 9.5, 100 mM NaCl, 5 mM MgCl and 16.5 btl
of 5-bromo-4 chloro-3-indolyl phosphate (BCIP,
Sigma). After the colour had developed to the de-
sired intensity, the reaction was stopped by replacing
the substrate solution with stop solution (20 mM
Tris-HCl pH 8.0 and 5 mM EDTA).
All samples were evaluated in duplicate. Statistical
analysis was performed using analysis of variance.
When the F value was significant, differences be-
tween mean values were evaluated employing the
least significant difference. As used throughout this
study, significance indicates p < 0.05.
Results
The effect of varying concentrations of LPC on gall-
bladder mucosal cell integrity was evaluated in a
variety of ways. LDH is a lysosomal enzyme com-
monly measured in tissue culture media as an index
of the amount of cellular contents lost through dam-
aged cell membranes. 16 As seen in Table 1, there was
a statistically significant increase in the concentra-
tions of LDH in cells exposed to LPC compared with
cells maintained only in control buffer solution.
Whereas the LDH changes suggested that exposure
to LPC may produce some cell damage, when cell
morphology, attachment to basement membrane
substrate or Trypan Blue exclusion were evaluated,
we were unable to detect any differences between
control cells in buffer solution and cells exposed to
1.5 mM concentrations of LPC.
As seen in Table 1, LPC produced dose-related
increases in 6-keto-PGFl and PAF concentrations in
buffer solution, while PGE concentrations were un-
changed. Results are presented by reference to 1 x
106 cells and were similar when evaluated by refer-
ence to mg cell protein. The results suggested that
LPC was a significant stimulant of the hydrolysis of
the SN-2 fatty acid chain of phospholipids leading to
the formation of PAF and of COX activity producing
arachidonic acid metabolites.
To obtain further evidence that LPC stimulated
synthesis of COX, microsomal proteins were
fractionated by SDS polyacrylamide gel
electrophoresis, electroblotted on nitrocellulose fil-
ters and treated with anti-COX-1 and anti-COX-2
antibodies. In control buffer solutions and in buffer
solutions from LPC stimulated gall-bladder mucosal
cells COX-1 protein was not detectable or barely
detectable suggesting that the expression of the con-
stitutive COX-1 enzyme was not significantly in-
creased (Fig. 1). As seen in Fig. 2, LPC treatment
induced increased expression of inducible COX-2 as
demonstrated by the rabbit anti-COX-2 antibody.
These results support the conclusion that LPC stimu-
lates de novo synthesis of 72 kDa inducible COX-2
enzyme19,2 in human gall-bladder mucosal cells.
Discussion
The results of the present study suggest that a
cytolytic, membrane perturbing substance present in
bile, LPC, produces significant changes in COX and
phospholipase a metabolism by human gall-bladder
mucosal cells. While the changes in LDH levels
indicate some limited membrane damage may be
occurring,
21 the evidence suggests that LPC has direct
stimulatory activity on phospholipase A and COX
enzymes. Support for this conclusion is related to the
specificity of the changes in PAF and prostanoid
formation with increased prostacyclin formation and
the increased expression of inducible COX-2 in re-
sponse to LPC stimulation.
COX-1 protein was not detectable or barely detect-
able and did not appear to be inducible by LPC. This
is true in other systems as well. In skin inflammation,
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Table 1. The effect of lysophosphatidylcholine (LPC) on prostanoid and PAF production and LDH release
by human gall-bladder mucosal cells.
LPC (mM)
Control 0.1 0.25 0.5 1.0 1.5
PGE (pg/ml) 62 + 24 53 +/- 18 45 +/- 12 44 +/- 11 32 +/- 8 30 +/- 9
6-keto-PGF1, (pg/ml) 88 +/- 30 125 +/- 35 170 +/- 27 219 +/- 24 417 +/- 54* 780 +/- 147"
PAF (ng/ml) 1.0 +/- 0.3 4.4 +/- 0.5 10.1 +/- 2.6 13.1 + 2.6* 20.8 +/- 5.3* 22.4 +/- 5.0*
LDH (mU/L) 25 +/- 3 39 +/- 7 86 +/- 16" 89 +/- 13" 78 + 17" 89 +/- 9*
Each value represents the mean +/- S.E.M. of five values obtained from the mean of duplicate levels from
five gall-bladders. An asterisk indicates that the value is significantly different from control. x 106 mucosal
cells were incubated in buffer solution for h alone and with varying concentrations of LPC.
70-72 kDa
2 3 4 5
2 3 4 5
70-72 kDa
FIG. 1. Evaluation of microsomal COX-1 expression by unstimulated and
LPC-treated human gall-bladder mucosal cells. Lanes and 2 represent 15
ng of microsomal protein from control buffer treated cells with no LPC and
Lanes 3 and 4 represent 15 ng of protein from cells treated with LPC. In
three separate gall-bladder specimens, COX-1 was not detectable or only
barely detectable. Lane 5 is COX-1 protein as positive control.
Western blot analysis was unable to detect COX-1
protein in normal or inflamed skin, while COX-2
expression was increased by pro-inflammatory
agents.
22 Similarly, in human endothelial cells COX-
1 expression was not detected employing Northern
blot analysis unless a sensitive reverse transcription,
polymerase chain reaction assay was employed. 23,24
Determination of the relative contributions of COX-
1 and COX-2 to prostanoid formation in stimulated
and-unstimulated gall-bladder mucosal cells will
require continued evaluation with LPC and other
pro-inflammatory agents.
In previous studies in cats, experimental
cholecystitis was produced by lipopolysaccharide
administration. 15 Human gall-bladder mucosal cells
exposed to lipopolysaccharide produce large
amounts of PAF and prostanoids.
11 Interestingly, the
FIG. 2. Effect of LPC on microsomal COX-2 protein expression. Human
gall-bladder mucosal cells were treated with 0.5 mM LPC for h. The
microsomal protein was prepared and analysed by Western blotting. Each
lane represents protein from mucosal cells from a single gall-bladder.
Lanes and 2 represent 15 lg of microsomal protein from control, buffer
treated cells with no LPC and Lanes 3 and 4 represent 15 lg of protein from
cells treated with LPC immunoblotted with rabbit anti-COX-2 antibody. The
molecular weight marker identifies the 70-72 kDa COX protein. Lane 5
represents 100 ng of protein as a positive control. In three gall-bladder
specimens COX-2 protein expression was induced by LPC.
pro-inflammatory stimuli lipopolysaccharide and LPC
produce relatively specific changes in arachidonic
acid metabolism. Lipopolysaccharide did not change
6-keto-PGFl production by human gall-bladder
mucosal cells, while the stimulus markedly increased
PGE production. As indicated in the present study,
LPC produced primarily increased prostacyclin for-
mation.
In intact animals, it is possible to produce a severe
tissue destructive, inflammatory disorder in the gall-
bladder that mimics the inflammatory disorder in
humans. 7,9,15,25 In isolated human gall-bladder
mucosal cells it is presently unclear what causes the
cellular damage evident in cholecystitis. As PAF pro-
duced a remarkable degree of tissue destruction in
vivo, it was felt that this substance, if produced by
gall-bladder cells by increased phospholipase a
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activity, may contribute to or produce the cell lysis.
As is evident in this study and as found previously
with lipopolysaccharide,
11 human gall-bladder
mucosal cells exposed to large amounts of intra and
extracellular PAF remain physically intact. As the
question is relevant not only to cholecystitis, but to
other gastrointestinal inflammatory disorders as well,
further studies will be needed in order to clarify the
nature of the-tissue destructive agents. While
phospholipase a and COX activity may be relevant
in developing the inflammatory cascade of events, it
seems unlikely that their products cause the cellular
damage. Other potential factors that may contribute
to the tissue destruction include ischaemia,
ischaemia/reperfusion,
26 nitric oxide,27 or factors pro-
duced by leukocytes and macrophages.
28
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